The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes

Objectives: To investigate the frequency of the ACTN3 R577X polymorphism in elite endurance triathletes, and whether ACTN3 R577X is significantly associated with performance time. Design: Cross-sectional study. Methods: Saliva samples, questionnaires, and performance times were collected for 196 eli...

Full description

Bibliographic Details
Main Authors: Grealy, R., Smith, C., Chen, T., Hiller, D., Haseler, Luke, Griffiths, L.
Format: Journal Article
Published: Elsevier Australia 2013
Online Access:http://hdl.handle.net/20.500.11937/62946
_version_ 1848760952536694784
author Grealy, R.
Smith, C.
Chen, T.
Hiller, D.
Haseler, Luke
Griffiths, L.
author_facet Grealy, R.
Smith, C.
Chen, T.
Hiller, D.
Haseler, Luke
Griffiths, L.
author_sort Grealy, R.
building Curtin Institutional Repository
collection Online Access
description Objectives: To investigate the frequency of the ACTN3 R577X polymorphism in elite endurance triathletes, and whether ACTN3 R577X is significantly associated with performance time. Design: Cross-sectional study. Methods: Saliva samples, questionnaires, and performance times were collected for 196 elite endurance athletes who participated in the 2008 Kona Ironman championship triathlon. Athletes were of predominantly North American, European, and Australian origin. A one-way analysis of variance was conducted to compare performance times between genotype groups. Multiple linear regression analysis was performed to model the effect of questionnaire variables and genotype on performance time. Genotype and allele frequencies were compared to results from different populations using the chi-square test. Results: Performance time did not significantly differ between genotype groups, and age, sex, and continent of origin were significant predictors of finishing time (age and sex: p < 5×10 -6 ; continent: p=0.003) though genotype was not. Genotype and allele frequencies obtained (RR 26.5%, RX 50.0%, XX 23.5%, R 51.5%, X 48.5%) were found to be not significantly different from Australian, Spanish, and Italian endurance athletes (p > 0.05), but were significantly different from Kenyan, Ethiopian, and Finnish endurance athletes (p < 0.01). Conclusions: Genotype and allele frequencies agreed with those reported for endurance athletes of similar ethnic origin, supporting previous findings for an association between 577X allele and endurance. However, analysis of performance time suggests that ACTN3 does not alone influence endurance performance, or may have a complex effect on endurance performance due to a speed/endurance trade-off. © 2012 Sports Medicine Australia.
first_indexed 2025-11-14T10:23:57Z
format Journal Article
id curtin-20.500.11937-62946
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:23:57Z
publishDate 2013
publisher Elsevier Australia
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-629462018-02-06T06:24:14Z The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes Grealy, R. Smith, C. Chen, T. Hiller, D. Haseler, Luke Griffiths, L. Objectives: To investigate the frequency of the ACTN3 R577X polymorphism in elite endurance triathletes, and whether ACTN3 R577X is significantly associated with performance time. Design: Cross-sectional study. Methods: Saliva samples, questionnaires, and performance times were collected for 196 elite endurance athletes who participated in the 2008 Kona Ironman championship triathlon. Athletes were of predominantly North American, European, and Australian origin. A one-way analysis of variance was conducted to compare performance times between genotype groups. Multiple linear regression analysis was performed to model the effect of questionnaire variables and genotype on performance time. Genotype and allele frequencies were compared to results from different populations using the chi-square test. Results: Performance time did not significantly differ between genotype groups, and age, sex, and continent of origin were significant predictors of finishing time (age and sex: p < 5×10 -6 ; continent: p=0.003) though genotype was not. Genotype and allele frequencies obtained (RR 26.5%, RX 50.0%, XX 23.5%, R 51.5%, X 48.5%) were found to be not significantly different from Australian, Spanish, and Italian endurance athletes (p > 0.05), but were significantly different from Kenyan, Ethiopian, and Finnish endurance athletes (p < 0.01). Conclusions: Genotype and allele frequencies agreed with those reported for endurance athletes of similar ethnic origin, supporting previous findings for an association between 577X allele and endurance. However, analysis of performance time suggests that ACTN3 does not alone influence endurance performance, or may have a complex effect on endurance performance due to a speed/endurance trade-off. © 2012 Sports Medicine Australia. 2013 Journal Article http://hdl.handle.net/20.500.11937/62946 10.1016/j.jsams.2012.08.013 Elsevier Australia restricted
spellingShingle Grealy, R.
Smith, C.
Chen, T.
Hiller, D.
Haseler, Luke
Griffiths, L.
The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes
title The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes
title_full The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes
title_fullStr The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes
title_full_unstemmed The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes
title_short The genetics of endurance: Frequency of the ACTN3 R577X variant in Ironman World Championship athletes
title_sort genetics of endurance: frequency of the actn3 r577x variant in ironman world championship athletes
url http://hdl.handle.net/20.500.11937/62946